ClinicalTrials.Veeva

Menu

Endothelial Function in Prehypertension

J

Josip Juraj Strossmayer University of Osijek

Status

Not yet enrolling

Conditions

Hypertension,Essential

Study type

Observational

Funder types

Other

Identifiers

NCT06316271
PreHT 2024

Details and patient eligibility

About

In the frame of this proposal investigators will test the hypothesis that high normal blood pressure (prehypertension; PreHT) induces systemic endothelial dysfunction and endothelial activation in both micro- and macrocirculation, reduces re-endothelialization potential of human endothelial progenitor cells (EPCs) and increases the level of endothelial extracellular vesicles (EVs), which are accompanied by increased oxidative stress level. Furthermore, initial vascular and left ventricle (LV) remodeling contributes to changes in systemic hemodynamics and may be influenced by altered regulatory role of renin-angiotensin system (RAS) and autonomic nervous system (ANS) in PreHT but otherwise healthy individuals. To distinguish high normal blood pressure effect from those considered normal or high, study will be performed in three groups of individuals: prehypertensive (BP 130-139/85-89 mmHg), hypertensive (stage I, BP 140-150/90-100 mmHg), and controls (BP less than or equal to 129/85 mmHg). Altogether, the impairment of normal vascular relaxation mechanisms, endothelial activation as well as vascular and LV remodeling could play crucial role in increased cardiovascular risk and CVDs incidence in PreHT individuals. Moreover, the prognostic significance of assessing endotehlial dysfunction in hypertension (as well as in PreHT) is yet to be established.

Enrollment

90 estimated patients

Sex

All

Ages

18 to 69 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • adults of both sexes with normotensive, prehypertensive and grade I hypertension blood pressure values

Exclusion criteria

  • cardiovascular diseases, but grade I hypertension (BP 140-150/90-100 mmHg)
  • diabetes
  • kidney disease
  • cerebrovascular diseases
  • peripheral artery disease
  • taking oral contraceptives or any drugs that could affect the endothelium

Trial design

90 participants in 3 patient groups

Normotensive Group
Description:
BP less than or equal to 129/84 mmHg
Prehypertensive Group
Description:
BP 130-139/85-89 mmHg
Hypertensive Group
Description:
BP 140-150/90-100 mmHg

Trial contacts and locations

1

Loading...

Central trial contact

Ines Drenjančević, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems